Efficacy of accelerated dose titration of olanzapine with adjunctive lorazepam to treat acute agitation in schizophrenia - 26/08/11
Abstract |
We conducted a prospective double-blind study of accelerated dose titration of olanzapine in the treatment of newly admitted acutely agitated patients with schizophrenia. Patients were randomized to either oral olanzapine (10 mg per day) or oral haloperidol (10 mg per day), plus lorazepam as needed (up to 12 mg per day). Antipsychotic dosage was increased to 20 mg per day as early as day 3. Patients were evaluated with the Positive and Negative Syndrome Scale (PANSS) Agitation subscale during the first 24 hours of treatment, daily for the first week, then weekly until study completion. Significant within-group improvement was demonstrated in PANSS Agitation scores for both groups as early as 1 hour after initiating therapy (−5.79 ± 6.30 for olanzapine and −4.89 ± 6.05 for haloperidol, P <.001). This study demonstrated that accelerated dose titration of oral olanzapine is as efficacious as oral haloperidol in reducing acute agitation in patients with schizophrenia.
Le texte complet de cet article est disponible en PDF.Keywords : Olanzapine, acute agitation, dosing, schizophrenia, behavioral emergency, haloperidol, adjunctive lorazepam
Plan
Vol 22 - N° 3
P. 181-186 - mai 2004 Retour au numéro
Article précédent
- Comparison of EPs’ and psychiatrists’ laboratory assessment of psychiatric patients
- Leslie s Zun, Roma Hernandez, Randy Thompson, Lavonne Downey
- Patterns of complementary and alternative medicine use in ED patients and its association with health care utilization
- J.Z Li, J.V Quinn, C.E McCulloch, B.P Jacobs, P.V Chan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?